This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: A Randomized Clinical Trial
JAMA:2022: March 14 Full text
Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial.
JAMA:2022: March 22 Full text
Clinical Practice
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries.
European Heart Journal:2022: 43(11):1104-20 Full text
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis.
European Heart Journal:2022: 43(11):1033-58 Full text
Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology.
European Journal of Preventive Cardiology:2022: March 10 Full text
Infection Control
Comparative effectiveness of single vs repeated rapid SARS-CoV-2 antigen testing among asymptomatic individuals in a workplace setting.
JAMA Network Open:2022: March 18 Full text
Pathophysiology, Epidemiology and Long COVID
Cognitive dysfunction following SARS-CoV-2 infection in a population-representative Canadian sample: A cross sectional study
Brain, Behavior & Immunity – Health:2022: March 21 Full text
Risks and burdens of incident diabetes in long COVID: a cohort study.
Lancet:2022: March Full text
Frailty and mortality associations in patients with COVID-19: a systematic review and meta-analysis. AUS
Internal Medicine Journal:2022: January 23 Full text
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Lancet:2022: March 16 Full text
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep2020- May 2021) in the Veneto Oncology Network: the ROVID study.
European Journal of Cancer:2022: March 18 Full text
Vaccines
Durability of the single-dose Ad26.COV2.S vaccine in the prevention of COVID-19 infections and hospitalizations in the us before and during the delta variant surge.
JAMA Network Open:2022: March 17 Full text
Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine.
New England Journal of Medicine:2022: March 23 Full text
Vaccine Adverse Effects
COVID-19 mRNA vaccines and myopericarditis. AUS
Internal Medicine Journal:2022: March 15 Full text
Myocarditis following a third BNT162b2 vaccination dose in military recruits in israel.
JAMA Network Open:2022: March 17 Full text
Immunology
Age-varying susceptibility to the delta variant (B.1.617.2) of SARS-CoV-2
JAMA Network Open:2022: March 18 Full text
Psychosocial Factors
The interface of COVID-19, diabetes, and depression.
Discover Mental Health:2022:2(5) Full text
Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine.
New England Journal of Medicine:2022: March 23 Full text
